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The Globalization of Multinational Enterprise R & D and Procurement of Technology
Hitoshi Furui
This paper studies overseas research ventures undertaken by multinational enterpns-
es, focusing on the selection of a rese;びdi partne:L R & D alliances (1…e. COmmissioning R
& D, Joint R & D) Technology acquisitions (licensing in), outsourcing, and M & A be-
tween Japanese丘rms and foreign血蝣ms are increasing due to global mega competition. R
& D alliances have become more and more important not only缶蝣om the viewpoint of
comparative advantage strategy but also from procurement of technology.
R & D alliances have been made not only among large飯蝣ms but also between venture
飯ins and large丘irms. Why have large丘irms been swept away? Why have large Japanese
伝rms engaged in research overseas and participated in R & D joint ventures? Is it related
to the behavior of large血ms? The question is dealt with theoretically, focusing on the
foreign technology owner. The foreign血m possesses the scientific knowledge or tech-
nology, and necessarily selects its preferred partner, which will be the血m that is eager
to pay the highest bid price for technology. Large丘irms are able to bid more than small
伝rms. Because large五inns (with a I喝;er market base) will e肝a more丘om the new tech-
nology than small丘inns. Therefore large血ms are o:氏;en the preferred partner.
